BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31109697)

  • 21. A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.
    De Ruyck K; Duprez F; Ferdinande L; Mbah C; Rios-Velazquez E; Hoebers F; Praet M; Deron P; Bonte K; Speel EJ; Libbrecht L; De Neve W; Lambin P; Thierens H
    Cancer Epidemiol; 2014 Oct; 38(5):591-8. PubMed ID: 25127693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus-related oropharyngeal cancer.
    Taberna M; Mena M; Pavón MA; Alemany L; Gillison ML; Mesía R
    Ann Oncol; 2017 Oct; 28(10):2386-2398. PubMed ID: 28633362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma.
    Kylmä AK; Jouhi L; Listyarifah D; Mohamed H; Mäkitie A; Remes SM; Haglund C; Atula T; Nieminen MT; Sorsa T; Hagström J
    Br J Cancer; 2018 Jul; 119(1):89-95. PubMed ID: 29930251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tobacco abuse on major chromosomal instability in human papilloma virus 16-positive oropharyngeal squamous cell carcinoma.
    Villepelet A; Hugonin S; Atallah S; Job B; Baujat B; Lacau St Guily J; Lacave R
    Int J Oncol; 2019 Aug; 55(2):527-535. PubMed ID: 31268157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation.
    Beaty BT; Moon DH; Shen CJ; Amdur RJ; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman TG; Thorp B; Blumberg JM; Patel SN; Weissler MC; Yarbrough WG; Sheets NC; Parker JS; Neil Hayes D; Weck KE; Ramkissoon LA; Mendenhall WM; Dagan R; Tan X; Gupta GP; Chera BS
    J Natl Cancer Inst; 2020 Aug; 112(8):855-858. PubMed ID: 31747025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
    Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
    Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.
    Miller DL; Davis JW; Taylor KH; Johnson J; Shi Z; Williams R; Atasoy U; Lewis JS; Stack MS
    Am J Pathol; 2015 Mar; 185(3):679-92. PubMed ID: 25572154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B
    Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma: A bioinformatics study.
    Wang J; Xi X; Shang W; Acharya A; Li S; Savkovic V; Li H; Haak R; Schmidt J; Liu X; Deng Y; Pan H; Obradovic D; Schmalz G; Ziebolz D; Hu X
    Am J Otolaryngol; 2019; 40(4):547-554. PubMed ID: 31036418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Schrank TP; Lenze N; Landess LP; Hoyle A; Parker J; Lal A; Sheth S; Chera BS; Patel SN; Hackman TG; Major MB; Issaeva N; Yarbrough WG
    Cancer; 2021 Aug; 127(15):2788-2800. PubMed ID: 33819343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common fragile sites (CFS) and extremely large CFS genes are targets for human papillomavirus integrations and chromosome rearrangements in oropharyngeal squamous cell carcinoma.
    Gao G; Johnson SH; Vasmatzis G; Pauley CE; Tombers NM; Kasperbauer JL; Smith DI
    Genes Chromosomes Cancer; 2017 Jan; 56(1):59-74. PubMed ID: 27636103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
    Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis.
    Huebbers CU; Verhees F; Poluschkin L; Olthof NC; Kolligs J; Siefer OG; Henfling M; Ramaekers FCS; Preuss SF; Beutner D; Seehawer J; Drebber U; Korkmaz Y; Lam WL; Vucic EA; Kremer B; Klussmann JP; Speel EM
    Int J Cancer; 2019 May; 144(10):2465-2477. PubMed ID: 30367463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas.
    Gao G; Wang J; Kasperbauer JL; Tombers NM; Teng F; Gou H; Zhao Y; Bao Z; Smith DI
    BMC Cancer; 2019 Apr; 19(1):352. PubMed ID: 30975103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma.
    Schlecht NF; Ben-Dayan M; Anayannis N; Lleras RA; Thomas C; Wang Y; Smith RV; Burk RD; Harris TM; Childs G; Ow TJ; Prystowsky MB; Belbin TJ
    Cancer Med; 2015 Mar; 4(3):342-53. PubMed ID: 25619363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association.
    Biron VL; Côté DW; Seikaly H
    J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S65-9. PubMed ID: 21453664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.
    Kumar B; Brown NV; Swanson BJ; Schmitt AC; Old M; Ozer E; Agrawal A; Schuller DE; Teknos TN; Kumar P
    Oncotarget; 2016 Apr; 7(14):18665-77. PubMed ID: 26919244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
    Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
    Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.